[Endocrine disrupters: Towards an unsatisfying regulation]

Presse Med. 2018 Nov-Dec;47(11-12 Pt 1):943-949. doi: 10.1016/j.lpm.2018.08.001. Epub 2018 Sep 11.
[Article in French]

Abstract

Endocrine disruptors commonly make the headlines of newscasts and magazines, which is not without generating questions, even anxieties, with the general public. In a recent survey, 90% of French people considered it desirable to set up regulations concerning endocrine disruptors. However, under pressure from the lobbies of the chemical industry, and also due to scientific conflicts, the European Union is slow to legislate and has even been condemned before the European Court for failing to fulfill its obligations. This article does not intend to be exhaustive on the issue of endocrine disrupters, but rather to give the reader a certain number of keys enabling him to understand why national or European regulators are slow to establish specific regulation.

Publication types

  • Review

MeSH terms

  • Advisory Committees / standards
  • Consumer Behavior
  • Endocrine Disruptors*
  • Europe
  • France
  • Humans
  • Legislation, Medical / organization & administration
  • Legislation, Medical / standards
  • Legislation, Medical / trends*
  • Public Opinion

Substances

  • Endocrine Disruptors